Most bought healthcare stocks in Q3 2020
See which Healthcare stocks institutional investors increased the most in Q3 2020, measured as net growth in reported share positions from Q2 2020 into Q3 2020. Notable additions at the top of this list include MERCK & CO. INC. (MRK), BRISTOL-MYERS SQUIBB CO (BMY), ABBVIE INC (ABBV), PACIFIC BIOSCIENCES OF CALIF (PACB). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| MRK | MERCK & CO. INC. | 19,380,722 | $1.63B | 4 | 5 | 7 | 2 | 21 |
| BMY | BRISTOL-MYERS SQUIBB CO | 19,047,425 | $1.26B | 4 | 5 | 10 | 0 | 21 |
| ABBV | ABBVIE INC | 16,037,821 | $1.19B | 3 | 6 | 6 | 1 | 18 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 15,971,911 | $211.52M | 1 | 1 | 0 | 1 | 2 |
| PFE | PFIZER INC | 9,082,655 | $421.93M | 5 | 6 | 7 | 0 | 18 |
| AVTR | AVANTOR INC | 8,698,718 | $236.18M | 1 | 3 | 0 | 1 | 4 |
| EVH | EVOLENT HEALTH INC - A | 8,558,215 | $106.21M | 2 | 0 | 0 | 0 | 2 |
| CERS | CERUS CORP | 8,241,636 | $44.19M | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4,238,350 | $133.74M | 1 | 4 | 0 | 0 | 6 |
| UNH | UNITEDHEALTH GROUP INC | 4,013,948 | $1.60B | 4 | 6 | 12 | 2 | 25 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,673,468 | $144.10M | 1 | 1 | 0 | 0 | 2 |
| PMVP | PMV PHARMACEUTICALS INC | 2,641,840 | $93.78M | 1 | 0 | 0 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | 2,617,278 | $61.04M | 0 | 1 | 1 | 1 | 2 |
| TDOC | TELADOC HEALTH INC | 2,395,203 | $534.46M | 2 | 4 | 1 | 0 | 7 |
| CNC | CENTENE CORP | 2,214,553 | $37.39M | 3 | 3 | 0 | 0 | 6 |
| ATHA | ATHIRA PHARMA INC | 2,120,653 | $39.15M | 1 | 0 | 0 | 0 | 1 |
| VCYT | VERACYTE INC | 1,980,626 | $97.72M | 1 | 1 | 0 | 0 | 2 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | 1,900,000 | $105.64M | 2 | 0 | 0 | 0 | 2 |
| ONVO | ORGANOVO HOLDINGS INC | 1,848,747 | $14.62M | 2 | 0 | 0 | 0 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 1,516,988 | $165.65M | 0 | 1 | 0 | 0 | 1 |
| CLLS | CELLECTIS - ADR | 1,355,756 | $27.03M | 0 | 1 | 0 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,325,491 | $12.53M | 1 | 0 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1,250,137 | $199.10M | 3 | 1 | 4 | 2 | 8 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 1,240,327 | $21.48M | 2 | 1 | 1 | 0 | 4 |
| PSNL | PERSONALIS INC | 1,238,258 | $44.83M | 1 | 1 | 0 | 0 | 2 |
| ELV | ELEVANCE HEALTH INC | 1,128,185 | $344.84M | 3 | 6 | 3 | 0 | 13 |
| ISRG | INTUITIVE SURGICAL INC | 971,321 | $734.40M | 4 | 3 | 1 | 1 | 8 |
| NVS | NOVARTIS AG-SPONSORED ADR | 959,690 | $72.26M | 2 | 2 | 5 | 0 | 10 |
| ACCD | ACCOLADE INC | 893,584 | $34.73M | 2 | 0 | 0 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | 860,513 | $138.71M | 3 | 1 | 3 | 0 | 7 |
| BDX | BECTON DICKINSON AND CO | 800,805 | $113.85M | 2 | 4 | 6 | 0 | 14 |
| CDNA | CAREDX INC | 754,125 | $31.81M | 1 | 1 | 0 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 717,516 | $4.18M | 0 | 1 | 0 | 0 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 703,434 | $29.00M | 1 | 2 | 0 | 0 | 3 |
| CORT | CORCEPT THERAPEUTICS INC | 686,000 | $17.16M | 0 | 1 | 0 | 0 | 1 |
| OMI | OWENS & MINOR INC | 674,217 | $59.03M | 1 | 1 | 0 | 0 | 2 |
| ILMN | ILLUMINA INC | 636,171 | $122.94M | 3 | 4 | 1 | 0 | 8 |
| CAH | CARDINAL HEALTH INC | 626,510 | $1.80M | 1 | 3 | 2 | 1 | 6 |
| ARCT | ARCTURUS THERAPEUTICS HOLDIN | 577,007 | $17.39M | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 575,584 | $36.44M | 0 | 1 | 0 | 0 | 2 |
| GILD | GILEAD SCIENCES INC | 536,424 | -$351.95M | 3 | 8 | 3 | 0 | 14 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 525,900 | $18.55M | 0 | 2 | 1 | 0 | 3 |
| PODD | INSULET CORP | 513,391 | $143.10M | 3 | 1 | 1 | 0 | 5 |
| FATE | FATE THERAPEUTICS INC | 478,192 | $24.89M | 2 | 1 | 0 | 0 | 3 |
| EHC | ENCOMPASS HEALTH CORP | 471,843 | $39.77M | 1 | 2 | 1 | 0 | 4 |
| PHR | PHREESIA INC | 470,654 | $15.36M | 0 | 1 | 1 | 0 | 2 |
| WAT | WATERS CORP | 470,476 | $154.51M | 1 | 2 | 1 | 0 | 5 |
| GH | GUARDANT HEALTH INC | 434,314 | $160.57M | 1 | 1 | 1 | 1 | 3 |
| BSX | BOSTON SCIENTIFIC CORP | 420,470 | $79.10M | 1 | 3 | 2 | 1 | 7 |
| SYK | STRYKER CORP | 406,426 | $332.85M | 4 | 4 | 2 | 1 | 10 |
Frequently asked questions about Most bought healthcare stocks in Q3 2020
What are the most bought Healthcare stocks in Q3 2020?
The most bought healthcare stocks in Q3 2020 are those with the largest increase in reported share counts across institutional investors compared to Q2 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2020?
Among filers in this sector, net additions were largest in companies such as MERCK & CO. INC. (MRK), BRISTOL-MYERS SQUIBB CO (BMY), ABBVIE INC (ABBV), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2020).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.